Vagus Nerve Stimulation Market Size, Latest Growth, Forecast By 2022 - 2030 | Cyberonics, Neurospace, electroCore

The rise in market expansion is driven by the growing occurrence of neurological disorders like migraine and epilepsy in people of all age groups due to changing lifestyles and promising clinical outcomes for these therapies. Based on product analysis, in 2021, the implantable VNS devices segment led the global market. By region, North America is expected to lead the market share in the projection period.

𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐀𝐝𝐝𝐫𝐞𝐬𝐬𝐞𝐬:
• The vagus nerve stimulation market was valued at USD 8.59 billion in 2021 and is expected to grow to USD 21.0 billion by 2030.
• The market is anticipated to exhibit a CAGR of 10.6% during the forecast period.
• The market is mainly segmented on the basis of product, application, biomaterial, end-use, and region.
• In 2022, North America accounted for the largest market share.

𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/vagus-nerve-stimulation-market/request-for-sample

𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
The vagus nerve, a lengthy nerve that extends from the brainstem to the abdomen, is crucial in controlling various physiological functions. Vagus nerve stimulation is a specialized medical therapy that utilizes an implanted device to send electrical signals to the vagus nerve. This treatment has displayed hopeful outcomes when used for specific neurological and psychiatric disorders. Many patients and healthcare providers find the therapy appealing due to its non-invasive nature, adjustability, and proven effectiveness. VNS devices come in both implantable and external forms for stimulating the vagus nerve.

𝐌𝐚𝐣𝐨𝐫 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:
With so many businesses involved, the market is projected to become more competitive as it continues to grow.
The report has covered the major players operating in the vagus nerve stimulation market:
• Cyberonics,
• Neurospace,
• electroCore,
• Medtronic,
• Cerebral Rx,
• LivaNova LLC,
• MicroTransponder, Inc., and
• NERVANA LLC.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞: https://www.polarismarketresearch.com/industry-analysis/vagus-nerve-stimulation-market/request-for-discount-pricing

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:
There is anticipated growth in the overall VNS market due to an increase in demand for automated vagus nerve stimulation methods among healthcare and medical professionals. Additionally, the increasing occurrence of neurological conditions like epilepsy, depression, and migraine, along with the growing popularity of less intrusive neurosurgical procedures, are key factors propelling the global vagus nerve stimulation market.

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:
• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭
• Implantable VNS Devices
• External VNS Devices

𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧
• Depression
• Epilepsy
• Migraine

𝐁𝐲 𝐁𝐢𝐨𝐦𝐚𝐭𝐞𝐫𝐢𝐚𝐥
• Metallics
• Ceramics
• Polymerics

𝐁𝐲 𝐄𝐧𝐝-𝐔𝐬𝐞
• Hospitals
• Ambulatory Surgical Centres (ASCS)
• Clinics
• Others

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/vagus-nerve-stimulation-market/inquire-before-buying

𝐕𝐚𝐠𝐮𝐬 𝐍𝐞𝐫𝐯𝐞 𝐒𝐭𝐢𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬
• Implantable VNS segment held the largest market share in the product segment due to rising technological advancements in the medical sector.
• Epilepsy held the largest segment in the application segment, with rising cases of migraine and obstructive sleep apnea.
• Clinics dominated the end use segment with rising therapeutics use of nerve stimulation.
• North America held the dominant position because of rising neurological diseases and the growing collaboration of major key players in this region.
• Major players operating in the industry include Cyberonics, Neurospace, electroCore, Medtronic, Cerebral Rx, LivaNova LLC, MicroTransponder, Inc., and NERVANA LLC.

𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭:
𝐒𝐞𝐥𝐟-𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/self-testing-market

𝐆𝐋𝐏-𝟏 𝐀𝐧𝐚𝐥𝐨𝐠𝐮𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/glp-1-analogues-market

𝐍𝐢𝐜𝐨𝐭𝐢𝐧𝐚𝐦𝐢𝐝𝐞 𝐀𝐝𝐞𝐧𝐢𝐧𝐞 𝐃𝐢𝐧𝐮𝐜𝐥𝐞𝐨𝐭𝐢𝐝𝐞 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/nicotinamide-adenine-dinucleotide-market

𝐌𝐮𝐥𝐭𝐢𝐨𝐦𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/multiomics-market

𝐕𝐨𝐢𝐜𝐞 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/voice-technology-in-healthcare-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.